3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Breast
1
Conditions
Breast Neoplasms
9
Anxiety Disorders
2
Smoking
1
Sleep Initiation and Maintenance Disorders
1
Prostatic Neoplasms
1
Pain
1
Neuropathy, Painful
1
Neurobehavioral Manifestations
1
Motor Activity
1
Lung Neoplasms
1
Depression
1
Colonic Neoplasms
1
Chronic Pain
1
Alcohol Drinking
1
Interventions
Zoledronic Acid
8
Psychiatric Rehabilitation
6
Analgesia
5
Acupuncture Therapy
5
Therapeutics
4
Bupivacaine
4
Surveys and Questionnaires
3
Radiotherapy
3
Ketamine
3
Early Intervention, Educational
3
Control Groups
3
Calcium
3
Yoga
2
Pregabalin
2
Music Therapy
2
Melatonin
2
Letrozole
2
Interviews as Topic
2
Fentanyl
2
Fatty Acids, Omega-3
2
Duloxetine Hydrochloride
2
Calcium Gluconate
2
Art Therapy
2
strontium chloride
1
pegfilgrastim
1
ixabepilone
1
exemestane
1
esmolol
1
cyclobenzaprine
1
Vitamin D
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pain
×
Mindfulness-Based Stress Reduction
×
Breast
×
Clear all
NCT02125006
2019-07-23
InDepth
Ottawa Hospital Research Institute
Phase NA
Completed
118 enrolled